Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948516 · ClinicalTrials.gov registry record
Sickle Cell Disease, Hemechip
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 738
- Enrollment target
NCT03948516 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 738 participants.
The verdict
NCT03948516 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 738 participants
- Enrollment target
Study Summary
Sickle cell disease is very common in Nigeria. Early diagnosis is important to prevent or reduce serious complications from the disease and to enable children stay healthy. To this end, the investigators would like to test a new, simple and quick device called the HemeChip to determine if it can detect whether or not someone has sickle cell disease. The investigators will compare the results obtained with the HemeChip with a standard method of diagnosing sickle cell disease known as Isoelectric focusing (IEF) or High Performance Liquid Chromatography (HPLC).If the investigators show that the new device can differentiate between children who have sickle cell disease and those who don't as successfully as the IEF or HPLC, they estimate a sharp increase in the use of this device in many countries especially in Africa due to its lower cost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 738 participants |
| Start Date | 2017-07-11 |
| Est. Completion | 2018-04-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03948516
The ClinicalTrials.gov registry entry for NCT03948516 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 738 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03948516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03948516 about?
NCT03948516 is a clinical study titled "Sickle Cell Disease, Hemechip". Sickle cell disease is very common in Nigeria. Early diagnosis is important to prevent or reduce serious complications from the disease and to enable children stay healthy. To this end, the investigators would like to test a new, simple and quick device called the HemeChip to determine if it can det...
What is the current status of trial NCT03948516?
This trial is currently completed. The enrollment target is 738 participants. The study started on 2017-07-11. Estimated completion is 2018-04-26.
Who is sponsoring clinical trial NCT03948516?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.